Joint with: Neurodegeneration: The Biological Pathways Driving the Future of Therapeutic Development
Neuro-Immune Interactions in the Central Nervous System
Jun 05–09, 2022 | Keystone Resort, Keystone, CO, United States
Scientific Organizers:
Marco Colonna, Shilpa Sambashivan and Michael T. Heneka
Livestream
In Person
On Demand
Jun 05–09, 2022 | Keystone Resort, Keystone, CO, United States
Scientific Organizers:
Marco Colonna, Shilpa Sambashivan and Michael T. Heneka
Available Formats:
Livestream
In Person
On Demand
Supported by the Directors' Fund
Important Deadlines
Early Registration Deadline:
Apr. 5, 2022
Scholarship Deadline:
Feb. 22, 2022
Global Health Award Deadline:
May. 26, 2022
Short Talk Abstract Deadline:
Deadlines not yet available for this meeting.
Poster Abstract Deadline:
Mar. 1, 2022
Meeting Summary
# Immunology
# Neurobiology
This conference aims to assemble leading geneticists, neuroscientists, and immunologists in an effort to explore important questions regarding the role of the immune system in the central nervous system during both health and disease. The goals of this meeting are the following: • Bring together different disciplines to investigate fundamental topics of neuroimmunology, such as immune control of CNS development, neuronal connectivity, myelination, circulation, as well as the role of the immune system in autoimmune and neurodegenerative diseases of the CNS. • Focus on the applications of emerging technologies to questions in neuroimmunology, such as -omics technologies, system biology and imaging. • Foster collaborations between immunologists, neuroscientists, and geneticists. • Encourage collaborations between academia and industry for the development of new avenues of intervention for multiple sclerosis and neurodegenerative diseases The anticipated outcomes of this meeting will include an increased awareness of the importance of the interplay between the immune system and the nervous system, the dissemination of the most up to date information in neuroimmunology, the application of new technologies to thus far intractable questions in neuroimmunology, and increased cross-discipline collaborations. This meeting will be held conjointly with the Keystone Meeting on Neurodegeneration; this combination will be beneficial in that it will emphasize the crossover between neurodegeneration and neuroimmunology. As neuroimmunology is a recently reinvigorated field this meeting will provide a critical opportunity to foster cross-disciplinary thinking.
SPECIAL RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR SPONSOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
KEYSTONE SYMPOSIA THANKS OUR MEETING EXHIBITOR(S):
KEYSTONE SYMPOSIA THANKS THESE DONOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
THESE COMPANIES HAVE GENEROUSLY AGREED TO COVER THE EXPENSES OF THEIR EMPLOYEES WHO ARE SPEAKING AT THIS MEETING:
GRANT RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS
Subscribe for Updates